Bihar Assembly Election 2025

Omicron Giving Rise To Many New Variants But No Need To Panic, Says NTAGI Chief Amid New Cases Of XE Variant

Covid Vaccine Update: Covishield Second Dose Gap Now Reduced To 8-16 Weeks — Details Here

Additional Covid Dose For Immunocompromised & Paediatric Vaccination: NTAGI To Take Call Today Amid Omicron Threat

30% Population 'Still Prone To Covid': Vaccine Panel Chief Warns Against Gatherings During Festivities

India vs Corona 3.0 e-Conclave: Green Passport Matter Should Be Resolved By August, Says NTAGI Chairman NK Arora

Single Dose Of Covishield 61% Effective; Will Revisit Vaccine Interval With Fresh Data: NTAGI Chief

'Decision Unanimous': Govt Counters NTAGI's Claim On Non Agreement For AstraZeneca's Covid Vaccine Interval